Annual Operating Profit
-$11.85 M
+$6.94 M+36.95%
30 September 2024
Summary:
Sonnet BioTherapeutics Holdings annual operaing income is currently -$11.85 million, with the most recent change of +$6.94 million (+36.95%) on 30 September 2024. During the last 3 years, it has risen by +$13.24 million (+52.77%). SONN annual operating profit is now -151.67% below its all-time high of -$4.71 million, reached on 30 September 2019.SONN Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$3.17 M
+$355.30 K+10.07%
30 September 2024
Summary:
Sonnet BioTherapeutics Holdings quarterly operating income is currently -$3.17 million, with the most recent change of +$355.30 thousand (+10.07%) on 30 September 2024. Over the past year, it has dropped by -$1.89 million (-148.14%). SONN quarterly operating profit is now -148.14% below its all-time high of -$1.28 million, reached on 31 December 2023.SONN Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$11.85 M
+$426.70 K+3.48%
30 September 2024
Summary:
Sonnet BioTherapeutics Holdings TTM operating income is currently -$11.85 million, with the most recent change of +$426.70 thousand (+3.48%) on 30 September 2024. Over the past year, it has increased by +$2.61 million (+18.05%). SONN TTM operating profit is now -775.09% below its all-time high of -$1.35 million, reached on 31 March 2020.SONN TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SONN Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +37.0% | -148.1% | +18.1% |
| 3 y3 years | +52.8% | +48.9% | +53.4% |
| 5 y5 years | -151.7% | - | - |
SONN Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +60.1% | -148.1% | +61.4% | at high | +60.1% |
| 5 y | 5 years | -151.7% | +60.1% | -148.1% | +61.4% | -775.1% | +60.1% |
| alltime | all time | -151.7% | +60.1% | -148.1% | +61.4% | -775.1% | +60.1% |
Sonnet BioTherapeutics Holdings Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | -$11.85 M(-36.9%) | -$3.17 M(-10.1%) | -$11.85 M(-3.5%) |
| June 2024 | - | -$3.53 M(-8.8%) | -$12.28 M(-3.1%) |
| Mar 2024 | - | -$3.87 M(+202.5%) | -$12.66 M(-12.4%) |
| Dec 2023 | - | -$1.28 M(-64.5%) | -$14.46 M(-23.1%) |
| Sept 2023 | -$18.79 M(-36.7%) | -$3.60 M(-8.1%) | -$18.79 M(-16.7%) |
| June 2023 | - | -$3.92 M(-30.9%) | -$22.57 M(-14.9%) |
| Mar 2023 | - | -$5.66 M(+0.9%) | -$26.52 M(-8.8%) |
| Dec 2022 | - | -$5.61 M(-23.9%) | -$29.07 M(-2.0%) |
| Sept 2022 | -$29.67 M | -$7.38 M(-6.2%) | -$29.67 M(+1.5%) |
| June 2022 | - | -$7.87 M(-4.2%) | -$29.24 M(+5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$8.21 M(+32.1%) | -$27.61 M(+8.5%) |
| Dec 2021 | - | -$6.21 M(-10.5%) | -$25.44 M(+1.4%) |
| Sept 2021 | -$25.09 M(+44.1%) | -$6.95 M(+11.3%) | -$25.09 M(-2.1%) |
| June 2021 | - | -$6.24 M(+3.4%) | -$25.63 M(+5.3%) |
| Mar 2021 | - | -$6.04 M(+3.0%) | -$24.33 M(+23.8%) |
| Dec 2020 | - | -$5.86 M(-21.7%) | -$19.65 M(+42.5%) |
| Sept 2020 | -$17.41 M(+269.8%) | -$7.49 M(+51.6%) | -$13.79 M(+119.0%) |
| June 2020 | - | -$4.94 M(+264.8%) | -$6.29 M(+364.8%) |
| Mar 2020 | - | -$1.35 M | -$1.35 M |
| Sept 2019 | -$4.71 M | - | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual operaing income?
- What is the all time high annual operating profit for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual operating profit year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly operating income?
- What is the all time high quarterly operating profit for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly operating profit year-on-year change?
- What is Sonnet BioTherapeutics Holdings TTM operating income?
- What is the all time high TTM operating profit for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings TTM operating profit year-on-year change?
What is Sonnet BioTherapeutics Holdings annual operaing income?
The current annual operating profit of SONN is -$11.85 M
What is the all time high annual operating profit for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual operaing income is -$4.71 M
What is Sonnet BioTherapeutics Holdings annual operating profit year-on-year change?
Over the past year, SONN annual operaing income has changed by +$6.94 M (+36.95%)
What is Sonnet BioTherapeutics Holdings quarterly operating income?
The current quarterly operating profit of SONN is -$3.17 M
What is the all time high quarterly operating profit for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly operating income is -$1.28 M
What is Sonnet BioTherapeutics Holdings quarterly operating profit year-on-year change?
Over the past year, SONN quarterly operating income has changed by -$1.89 M (-148.14%)
What is Sonnet BioTherapeutics Holdings TTM operating income?
The current TTM operating profit of SONN is -$11.85 M
What is the all time high TTM operating profit for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high TTM operating income is -$1.35 M
What is Sonnet BioTherapeutics Holdings TTM operating profit year-on-year change?
Over the past year, SONN TTM operating income has changed by +$2.61 M (+18.05%)